Scheme

BAN

ATC (Anatomical Therapeutic Chemical Classification)

D06BB04

CAS registry number (Chemical Abstracts Service)

0000518-28-5

Chemical Formula

C22-H22-O8

Molecular Weight

414

Therapeutic Categories

Dermatological agent

Topical antimitotic agent

Topical cytostatic agent

Chemical Name

Furo[3',4':6,7]naphto[2,3-d]-1,3-dioxol-6(5aH)-one, 5,8,8a,9-tetrahydro-9-hydroxy-5-(3,4,5-trimetoxyphenyl)-, [5R-(5α,5aβ,8aα,9α)]-

Foreign Names

• Podophyllotoxinum (Latin)
• Podophyllotoxin (German)
• Podophyllotoxine (French)

Generic Names

• Podofilox (OS: USAN)
• Podophyllotoxin (OS: BAN)
• Podophyllotoxine (OS: DCF)
• Podophyllotoxin (PH: Ph. Helv. 11)

Brand Names

• Condilom
  Bussié, Colombia; Bussié, Honduras
• Condiver
  Lacico, Colombia
• Condylin
  Takeda Austria, Bulgaria
• Condyline
  2care4, Norway; Astellas, Italy; Astellas, Kuwait; BModesto, Netherlands; Famar, Georgia; Galderma, Norway; Galderma Nordic, Denmark; Galderma Nordic, Sweden; Galderma Nordic AB, Finland; Galderma Nordic AB, Iceland; LEO Pharma, Netherlands; LEO Pharma, New Zealand; LEO Pharma, Poland; LEO Pharma, Romania; Medcor Pharmaceuticals, Netherlands; Orifarm, Norway; Sanofi-Aventis, Canada; Takeda, Australia; Takeda, Ireland; Takeda Pharma, Switzerland; Takeda UK, United Kingdom
• Condyline 0.5%
  LEO Pharma, France
• Condyline 5 mg/ml
  Takeda, Hungary
• Condylox
  Allergan, United States; Dr. August Wolff, Germany; Takeda, Israel; Tianjin Takeda Pharmaceutical, China
• Condylox 0.5%
  Takeda Pharma, Austria
• Podofilm
  Assos, Turkey; Paladin, Canada; Pharmascience, Hong Kong
• Podofilox
  Paddock Laboratories, United States
• Podox 0.5%
  Bussié, Colombia; Bussié, Dominican Republic; Bussié, Guatemala; Bussié, Honduras
• Podoxin
  Cassara, Argentina; Promofarma, Uruguay
• Posalfilin [+ Salicylic acid]
  Norgine, New Zealand
• Wartec
  BModesto, Netherlands; Dr. Fisher Farma, Netherlands; Euro Registratie, Netherlands; GlaxoSmithKline, Denmark; GlaxoSmithKline, Finland; GlaxoSmithKline, Lithuania; GlaxoSmithKline, Latvia; GlaxoSmithKline, Sweden; GlaxoSmithKline A.B.E.E., Greece; GlaxoSmithKline Australia, Australia; GSK, Czech Republic; Medcor Pharmaceuticals, Netherlands; Phoenix Labs, Netherlands; Stiefel, Brazil; Stiefel, China; Stiefel, Estonia; Stiefel, Spain; Stiefel, Hong Kong; Stiefel, Italy; Stiefel, Lebanon; Stiefel, Mexico; Stiefel, Oman; Stiefel, Romania; Stiefel, Slovakia; Stiefel, Taiwan; Stiefel, South Africa; Stiefel Laboratories Polska Sp. z.o.o., Poland
• Wartec 0.15%
  GlaxoSmithKline, Germany; GlaxoSmithKline, Finland; GlaxoSmithKline A.B.E.E., Greece; Stiefel, Germany
• Wartec 0.5%
  GlaxoSmithKline A.B.E.E., Greece
• Warticon
  Stiefel, United Kingdom; Stiefel, Ireland
• Warticon 0.5%
  GlaxoSmithKline, Cyprus
• You Tuo Xin
  Huawei Pharmaceutical, China

Glossary

Further information on drug naming conventions: International Nonproprietary Names.